Endomorphin-1 and endomorphin-2: Pharmacology of the selective endogenous μ-opioid receptor agonists

Pharmacology and Therapeutics

Volumn 88, Issue 3, 2000, Pages 437-463

  Horvath, Gyöngyi ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Opioid receptor; Antinociception; Cardiovascular; Endogenous peptide; Endomorphin 1; Endomorphin 2

Indexed keywords

ADENYLATE CYCLASE; BETA FUNALTREXAMINE; CALCIUM CHANNEL; CYPRODIME; DELTA OPIATE RECEPTOR; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLORNITHYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; DIPRENORPHINE; ENDOMORPHIN 1; ENDOMORPHIN 2; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2 DEXTRO ALANINE 5 DEXTRO LEUCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; ETHYLKETAZOCINE; GUANINE NUCLEOTIDE BINDING PROTEIN; KAPPA OPIATE RECEPTOR; MORPHINE; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; N,N DIALLYLTYROSYL 2 METHYLALANYL 2 METHYLALANYLPHENYLALANYLLEUCINE; NALOXONE; NALOXONE BENZOYLHYDRAZONE; NALTRINDOLE; NORBINALTORPHIMINE; POTASSIUM CHANNEL; U 65593; UNCLASSIFIED DRUG;

ANTINOCICEPTION; DRUG CONFORMATION; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; ENZYME INHIBITION; HUMAN; NONHUMAN; PAIN; PRIORITY JOURNAL; REVIEW;

ANALGESICS, OPIOID; ANIMALS; CARDIOVASCULAR PHYSIOLOGY; DIGESTIVE PHYSIOLOGY; ENDOTHELIUM; HUMANS; IMMUNE SYSTEM; INFLAMMATION; MAMMALS; NITRIC OXIDE; OLIGOPEPTIDES; RECEPTORS, OPIOID, MU; RESPIRATORY PHYSIOLOGY; SIGNAL TRANSDUCTION; VASODILATION;

EID: 0034450970     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(00)00100-5     Document Type: Review

References (106)

1. 35S]thio)triphosphate binding by endogenous opioids acting at a cloned μ receptor
2. Endomorphins have orexigenic and anxiolytic activities in mice
3. Maturation of endomorphin-2 in the dorsal horn of the medulla and spinal cord of the rat
4. The ontogeny of endomorphin-1- and endomorphin-2-like immunoreactivity in rat brain and spinal cord
5. Peripheral effects of opioid drugs on capsaicin-sensitive neurones of the guinea-pig bronchus and rabbit ear
6. Modulation of cholinergic neurotransmission in guinea-pig airways by opioids
7. Spinal antinociceptive effects and G-protein activation induced by endomorphin-1 in the rat
8. Evidence for κ- and μ-opioid receptor expression in C6 glioma cells
9. Drugs used to relieve pain
10. Specific G protein activation and μ-opioid receptor internalization caused by morphine, DAMGO and endomorphin 1
11. D-[Ala2]endomorphin 2 and endomorphin 2 have nitric oxide-dependent vasodilator activity in rats
12. 2]-endorphin 2 (TAPP) are mediated by an L-NAME-sensitive mechanism in the rat
13. The endogenous μ-opioid receptor agonists endomorphins 1 and 2 have novel hypotensive activity in the rabbit
14. The endogenous μ-opioid agonists, endomorphin 1 and 2, have vasodilator activity in the hindquarters vascular bed of the rat
15. Nitric oxide release mediates vasodilator responses to endomorphin 1 but not nociceptin/OFQ in the hindquarters vascular bed of the rat
16. Endomorphin 1 and 2, the endogen μ-opioid agonists, produce biphasic changes in systemic arterial pressure in the cat
17. Endomorphin 1 and 2 have vasodepressor activity in the anesthetized mouse
18. Endomorphin 1 and 2, endogenous ligands for the μ-opioid receptor, decrease cardiac output, and total peripheral resistance in the rat
19. Distinct inhibitory effects of spinal endomorphin-1 and endomorphin-2 on evoked dorsal horn neuronal responses in the rat
20. Molecular cloning and functional expression of a μ-opioid receptor from rat brain
21. Opioid receptor coupled second messenger systems
22. Endomorphin-1 and endomorphin-2, endogenous ligands for the μ-opioid receptor, inhibit electrical activity of rat rostral ventrolateral medulla neurons in vitro
23. μ-opioid receptor modulation of calcium channel current in periaqueductal grey neurons from C57B16/J mice and mutant mice lacking MOR-1
24. Opioids I
25. Endomorphin 1 and 2, endogenous μ-opioid agonists, decrease systemic arterial pressure in the rat
26. Depression of glutamatergic transmission by nociceptin in the neonatal rat hemisected spinal cord preparation in vitro
27. Preferred conformation of endomorphin-1 in aqueous and membrane-mimetic environments
28. Naloxone blocks endomorphin-1 but not endomorphin-2 induced inhibition of tachykinergic contractions of guinea-pig isolated bronchus
29. Pharmacological characterization of endomorphin-1 and endomorphin-2 in mouse brain
30. Endomorphins fully activate a cloned human μ opioid receptor
31. Isolation of relatively large amounts of endomorphin-1 and endomorphin-2 from human brain cortex
32. Endomorphin-1 mediates 2 Hz but not 100 Hz electroacupuncture analgesia in the rat
33. Lack of cross tolerance between the antinociceptive effect of intrathecal orphanin FQ and morphine in the rat
34. Isobolographic analysis of interaction between spinal endomorphin-1, a newly isolated endogenous opioid peptide, and lidocaine in the rat formalin test
35. Stimulatory effects of opioids
36. The effects of endomorphin-1 and endomorphin-2 in CHO cells expressing recombinant μ-opioid receptors and SH-SY5Y cells
37. Differential effects of endomorphin-1, endomorphin-2, and Tyr-W-MIF-1 on activation of G-proteins in SH-SY5Y human neuroblastoma membranes
38. Pre- and postsynaptic inhibitory actions of methionine-enkephalin on identified bulbospinal neurons of the rat RVL
39. Inhibition by nociceptin of neurogenic inflammation and the release of SP and CGRP from sensory nerve terminals
40. 2+ channel currents in rodent NG 108-15 cells overexpressing μ-opioid receptors
41. Intraplantar morphine significantly reduces spinal c-Fos expression induced by carrageenan inflammation but not by noxious heat
42. Antinociceptive effects of intrathecal endomorphin-1 and -2 in rats
43. Endomorphin-1 and endomorphin-2 are partial agonists at the human μ-opioid receptor
44. Endomorphin-1 reduces carrageenan-induced Fos expression in the rat spinal dorsal horn
45. 35S]GTPγS binding by endomorphin 1 and DAMGO in mouse brains
46. Modulation of peripheral inflammation by locally administered endomorphin-1
47. Endomorphins decrease heart rate and blood pressure possibly by activating vagal afferents in anesthetized rats
48. μ opioid receptor knockout in mice: Effects on ligand-induced analgesia and morphine lethality
49. Cardiovascular effects of nociceptin in unanesthetized mice
50. Properties of μ3 opiate alkaloid receptors in macrophages, astrocytes, and HL-60 human promyelocytic leukemia cells
51. Localization of endomorphin-2-like immunoreactivity in the rat medulla and spinal cord
52. Endomorphin-2 is an endogenous opioid in primary sensory afferent fibers
53. Differential distribution of endomorphin 1- and endomorphin 2-like immunoreactivities in the CNS of the rodent
54. Activation and internalization of the μ-opioid receptor by the newly discovered endogenous agonists, endomorphin-1 and endomorphin-2
55. Isolation and structure of the endogenous agonist of opioid receptor like ORL1 receptor
56. 2+ channel inhibition by endomorphins via the cloned μ-opioid receptor expressed in NG108-15 cells
57. The μ-opioid receptor gene-dose dependent reductions in G-protein activation in the pons/medulla and antinociception induced by endomorphins in μ-opioid receptor knockout mice
58. Specific activation of the μ opioid receptor (MOR) by endomorphin 1 and endomorphin 2
59. 2+ current in NG108-15 cells
60. 35S]GTPγS binding study and its practical application
61. 35S]GTPγS binding in the mouse spinal cord
62. Absence of G-protein activation by μ-opioid receptor agonist in the spinal cord of μ-opioid receptor knockout mice
63. Acute and chronic activation of the μ-opioid receptor with the endogenous ligand endomorphin differentially regulated adenylyl cyclase isoenzymes
64. Inhibitory effect of endomorphin-1 and -2 on acetylcholine release from myenteric plexus of guinea pig ileum
65. Drug receptors and the inhibition of nerve cells
66. Endogenous opiates: 1997
67. The loss of antinociceptive efficacy of spinal morphine in rats with nerve ligation injury is prevented by reducing spinal afferent drive
68. Modulation of acetylcholine release from parasympathetic nerves innervating guinea-pig and human trachea by endomorphin-1 and -2
69. Stereochemical requirements for receptor recognition of the μ-opioid peptide endomorphin-1
70. Central and peripheral inhibition of gastrointestinal transit in rats: Narcotics differ substantially by acting at either or both levels
71. Liquid chromatographic study of the enzymatic degradation of endomorphins, with identification by electrospray ionization mass spectrometry
72. Endomorphin-1 potentiates HIV-1 expression in human brain cell cultures: Implication of an atypical μ-opioid receptor
73. Immunoreactivity for endomorphin-2 occurs in primary afferents in rats and monkey
74. Conformation analysis of the endogenous μ-opioid agonist endomorphin-1 using NMR spectroscopy and molecular modeling
75. Pharmacological modulation of voltage dependent calcium channels in intact cells
76. Spinal analgesic action of endomorphins in acute, inflammatory and neuropathic pain in rats
77. Pain inhibition by endomorphins
78. Endomorphin-1 and -2 inhibit human vascular sympathetic norepinephrine release: Lack of interaction with μ3 opiate receptor subtype
79. Diprotin A, an inhibitor of dipeptidyl aminopeptidase IV (EC 3.4.14.5) produces naloxone-reversible analgesia in rats
80. Differential involvement of μ-opioid receptor subtypes in endomorphin-1 and -2-induced antinociception
81. Antisense oligodeoxynucleotide targeting distinct exons of the cloned μ-opioid receptor distinguish between endomorphin-1 and morphine supraspinal antinociception in mice
82. Endomorphin-1 and endomorphin-2 show differences in their activation of μ opioid receptor-regulated G proteins in supraspinal antinociception in mice
83. L-Glutamate and gamma-aminobutyric acid efflux from rat cerebrocortical synaptosomes: Modulation by κ- and μ- but not δ- and opioid receptor like-1 receptors
84. Immunofluorescent identification of endomorphin-2-containing nerve fibers and terminals in the rat brain and spinal cord
85. Modulation of endomorphin-2-induced analgesia by dipeptidyl peptidase IV
86. 35S]GTPγS binding in rat brain: Evidence for partial agonist activity at μ-opioid receptors
87. In vitro binding and signaling profile of the novel μ opioid receptor agonist endomorphin 2 in rat brain membranes
88. Expression of δ, κ and μ human opioid receptors in Escherichia coli and reconstitution of the high-affinity state for agonist with heterotrimeric G proteins
89. Opiate-like substances in an invertebrate, a novel opiate receptor on invertebrate and human immunocytes, and a role in immunosuppression
90. 3 opiate receptor in endothelial cells: Coupling to nitric oxide production and vasodilation
91. Peripheral mechanisms of opioid analgesia
92. Spinal analgesic actions of the new endogenous opioid peptides endomorphin-1 and -2
93. Antinociceptive effect and enzymatic degradation of endomorphin-1 in newborn rat spinal cord
94. Central effects of opioid agonists and naloxone on blood pressure and heart rate in normotensive and hypertensive rats
95. Endomorphin-1 and endomorphin-2 activate μ-opioid receptors in myenteric neurons of the guinea-pig small intestine
96. Differential antinociceptive effects of endomorphin-1 and endomorphin-2 in the mouse
97. Distinct effect of intracerebroventricular and intrathecal injections of nociceptin/orphanin FQ in the rat formalin test
98. Effects of orphanin FQ on endomorphin-1 induced analgesia
99. Release of endomorphin-2 like substances from the rat spinal cord
100. Endomorphin-like immunoreactivity in the rat dorsal horn and inhibition of substantia gelatinosa neurons in vitro
101. Itch-associated response and antinociception induced by intracisternal endomorphins in mice
102. A topochemical approach to explain morphiceptin bioactivity
103. Structure-activity relationships of naturally occurring and synthetic opioid tetrapeptides acting on locus coeruleus neurons
104. Involvement of μ-receptor in endogenous opioid peptide-mediated inhibition of acetylcholine release from the rat stomach
105. A potent and selective endogenous agonist for the μ-opiate receptor
106. Mu, and kappa opiate receptor binding of tyr-MIF-1 and of tyr-W-MIF-1, its active fragments, and two potent analogs